CURRICULUM VITAE MICHAEL I. KOUKOURAKIS

43
68. KOUKOURAKIS MI, Giatromanolaki A, Skarlatos J, Kosma L, Apostolikas N, Beroukas K. bcl-2 antiapoptotic
oncoprotein suppresses angiogenesis in non-small cell lung cancer. Implications in resistance to
photo-dynamic therapy ? In «SPIE. Proceedings Series», Vol 3423, pp 432-435; 1997
69. Giatromanolaki A, KOUKOURAKIS M et al,. Interleukin 4 receptor expression and metastasis in human
breast cancer. Recent advances in diagnostic imaging and supportive care in Oncology. 7 th European
Interuniversity symposium organized by the Aristoteles Institute. 1997
70. Giatromanolaki A, KOUKOURAKIS M et al. Angiogenesis is a significant prognostic marker in operable
non small cell lung cancer. Recent advances in diagnostic imaging and supportive care in Oncology. 7 th
European Interuniversity symposium organized by the Aristoteles Institute. 1997
71. Ververis C, Haldeoploulos D, KOUKOURAKIS M et al. External beam irradiation for unresectable
cancer of the colon and rectum. Recent advances in diagnostic imaging and supportive care in Oncology.
7 th European Interuniversity symposium organized by the Aristoteles Institute. 1997
72. KOUKOURAKIS M et al. Hypofractionated radiotherapy combined with 5FU in the treatment of locally
advanced breast carcinoma. Recent advances in diagnostic imaging and supportive care in Oncology. 7 th
European Interuniversity symposium organized by the Aristoteles Institute. 1997
73. Pissakas G, Sotiropoulou A, Varveris Ch, Kouvaris M, KOUKOURAKIS M, Kosma L. Palliation
of advanced pelvic malignancies after irradiation with multiple daily fraction. 1st International
Congress on cancer Pain relief and paliative care. November 1994, Athens
74. Pissakas G, Varveris Ch, Sotiropoulou A, KOUKOURAKIS M et al. Prophylactic versus symptomatic
irradiation of brain metastases from small cell carcinoma of the lung. 1st International Congress
on cancer Pain relief and paliative care. November 1994, Athens.
75. KOUKOURAKIS M, Giatromanolaki A, Gatter KC, Harris AL. Bcl-2 and c- erbB-2 gene products are
involved in the regulation of thymidine phospshorylase (PD-ECGF) angiogenic activity in NSCLC. 2nd
International Congress on Lung Cancer , Iraklion - Crete, 9-13 Nov 1996 Best oral
presentation Award
76. Giatromanolaki A, KOUKOURAKIS M, O;Byrne K, Gatter KC, Kittas C, Veslemes M, Iordanoglou I.
Prognostic role of EGFR and c-erbB-2oncogeneoverexpression in NSCLC. 2nd International Congress
on Lung Cancer , Iraklion - Crete, 9-13 Nov 1996
77. KOUKOURAKIS MI, Skarlatos J, Kosma L, Giatromanolaki A, Damilakis J, Yannakakis D. Overall
treatment time: a major factor influencing the results of radiotherapy for NSCLC. 2nd International
Congress on Lung Cancer , Iraklion - Crete, 9-13 Nov 1996
78. Koukouraki S, Giatromanolaki A, Damilakis J, Skarlatos J, Karkavitsas N, Kourakos C, Georgoulias V,
Kourousis H, KOUKOURAKIS M. Tc99m sestamibi radionuclide excretion rate in lung cancer: possible
implications in predicting multidrug resistance. 2nd International Congress on Lung Cancer ,
Iraklion - Crete, 9-13 Nov 1996
79. Giatromanolaki A, KOUKOURAKIS M, et al. Plasma cell, macrophage and tumour neoangiogenesis in
NSCLC. 2nd International Congress on Lung Cancer , Iraklion - Crete, 9-13 Nov 1996
80. KJ O'Byrne, M. KOUKOURAKIS, A Giatromanolaki et al. Tumour angiogenesis in non small cell lung
cancer.British Association for Cancer Research, Joint Winter Meeting, December 1995
81. KOUKOURAKIS M, Saunders M, AL. Harris. A pilot study of cyclophosphamide methotrexate and
infusional 5 fluorouracil for metastatic breast cancer.Imperial Cancer Research Fund , Annual
Coloquium, Worick, UK, March 1995.
82. KJ O'Byrne, C Thompson, V Macauley, M KOUKOURAKIS, SM Wilner, TS Ganesan, DC Talbot, AL
Harris. Bryostatin 1 in metastatic malignant melanoma.Irish Association for Cancer Research, 33rd
Annual Scientific Meeting, Limerick, April 1996
83. MI KOUKOURAKIS, KJ O'Byrne, MP Saunders, R Isaaks, VM Macauley, S Varcoe, TS ganesan, AL
Harris, DC talbot. A phase I/II study of cyclophosphamide, methotrexate and infusional 5-fluorouracil
(infusional CMF) in metastatic breast cancer.Irish Association for Cancer Research, 33rd Annual
Scientific Meeting, Limerick, April 1996
84. KJ O'Byrne, MI KOUKOURAKIS, A Giatromanolaki, R Whitehouse, DC Talbot, KC Gatter, Al Harris.
Bcl-2,c-erbB-2 and tumour angiogenesis in non-small cell lung cancer,Irish Association for Cancer
Research, 33rd Annual Scientific Meeting, Limerick, April 1996
85. KJ O'Byrne, A Giatromanolaki, M KOUKOURAKIS, M Comley, RM Whitehouse, DC Talbot, KC Gatter,
AL Harris. PD-ECGF expression correlates with tumour angiogenesis and prognosis in NSCLC.British
Association for Cancer Research, Spring Joint Meeting, March 1996
86. MI KOUKOURAKIS, KJ O'Byrne, MP Saunders, R. Isaaks, VM Macauley, S.Varkoe, TS Ganesan, AL
Haris, DC Talbot. Cyclophosphamide, Methotrexate and 5-fluorouracil (Infusional CMF) in metastatic
breast cancer. British Association for Cancer Research, Spring Joint Meeting, March 1996